Exendin-4, a glucagon-like peptide-1 receptor agonist, modulates hepatic fatty acid composition and Δ-5-desaturase index in a murine model of non-alcoholic steatohepatitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exendin-4, a glucagon-like peptide-1 receptor agonist, modulates hepatic fatty acid composition and Δ-5-desaturase index in a murine model of non-alcoholic steatohepatitis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Volume 34, Issue 3, Pages 782-787
Publisher
Spandidos Publications
Online
2014-06-27
DOI
10.3892/ijmm.2014.1826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice
- (2013) Nirav Dhanesha et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis
- (2013) Cristina López-Vicario et al. GUT
- GLP-1 Receptor Is Expressed in Human Stomach Mucosa
- (2013) Efrat Broide et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Variation in the FADS1/2 gene cluster alters plasma n−6 PUFA and is weakly associated with hsCRP levels in healthy young adults
- (2013) Kaitlin Roke et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
- (2013) Jamie Mells et al. SEMINARS IN LIVER DISEASE
- Dipeptidyl peptidase-4: A key player in chronic liver disease
- (2013) Minoru Itou WORLD JOURNAL OF GASTROENTEROLOGY
- The Glucagon-Like Peptide-1 Receptor Agonist Exendin 4 Has a Protective Role in Ischemic Injury of Lean and Steatotic Liver by Inhibiting Cell Death and Stimulating Lipolysis
- (2012) Nitika A. Gupta et al. AMERICAN JOURNAL OF PATHOLOGY
- Fenofibrate Increases High-Density Lipoprotein and Sphingosine 1 Phosphate Concentrations Limiting Abdominal Aortic Aneurysm Progression in a Mouse Model
- (2012) Smriti M. Krishna et al. AMERICAN JOURNAL OF PATHOLOGY
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling
- (2012) Kento Imajo et al. Cell Metabolism
- High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome
- (2012) Rie Matsumori et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study
- (2012) Yuichiro Eguchi et al. JOURNAL OF GASTROENTEROLOGY
- Gut microbiota produce alcohol in patients with NASH
- (2012) Katherine Smith Nature Reviews Gastroenterology & Hepatology
- Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
- (2012) Alexandra K. Leamy et al. PROGRESS IN LIPID RESEARCH
- Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in Japanese men and women
- (2011) Kalpana Poudel-Tandukar et al. ATHEROSCLEROSIS
- Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes
- (2011) Janine Kröger et al. CURRENT OPINION IN LIPIDOLOGY
- Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland
- (2011) Belinda Gier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
- (2011) Gianluca Svegliati-Baroni et al. LIVER INTERNATIONAL
- Exenatide in the Treatment of Diabetic Patients With Non-Alcoholic Steatohepatitis: A Case Series
- (2010) Patrick R Kenny et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease
- (2010) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance
- (2007) Minoru Itou et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started